Acupuncture With Deqi And Psychological Effects in Treatment of Bell's Palsy

Study of Effects of Deqi and Neuropsychological Factors on Acupuncture Effects in Treatment of Bell's Palsy

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT00685789

Acronym

ADAPT

Enrollment

355

Registered

2008-05-28

Start date

2008-10-31

Completion date

2010-12-31

Last updated

2011-09-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bell's Palsy

Keywords

Bell's palsy，deqi，acupuncture, neuropsychology

Brief summary

The purpose of this study is to observe the influence of Deqi and neuropsychological factors on effects of acupuncture treatment for Bell's Palsy.

Detailed description

Through long-term clinical practice，acupuncture treatment on facial paralysis has been generally proved effective；the large number of ancient and modern medical literature also have suggested that acupuncture is beneficial for facial paralysis. However,a scientific basis is still needed to be established to make sure the efficacy of acupuncture be recognized internationally.This study will adopt a series of international practice scales ,such as House Brackmann Scale,Facial Disability Index(FDI),World Health Organization Quality of Life-BREF (WHOQOL-BREF), Cattell Personality Factors (16PF),and Cancellation test to evaluate the role of deqi and neuropsychological factors in the acupuncture treatment for Bell's Palsy.

Interventions

DEVICEacupuncture, deqi

Immediately after insertion of a needle, it is manually rotated backwards and forwards to induce the deqi sensation.

DEVICEacupuncture Non-manipulation

After insertion of a needle, no manipulation is applied, and the needle is retained for 30 minutes.

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

TREATMENT

Masking

DOUBLE (Subject, Outcomes Assessor)

Eligibility

Sex/Gender

ALL

Age

18 Years to 65 Years

Healthy volunteers

Inclusion criteria

1. Patients who were diagnosed to have unilateral facial-nerve weakness without any identifiable causes within 168 hours after onset of symptoms; 2. aged 18 to 65 years.

Exclusion criteria

： 1. illiterate; 2. the facial paralysis is caused by herpes zoster; 3. recurrent facial paralysis; 4. noticeable asymmetry of the face before the illness which may affect the evaluation; 5. history of peptic ulcer disease, severe hypertension, uncontrolled diabetes, liver and kidney dysfunction, pregnancy, mental illness, or serious systemic diseases which may affect the treatment.

Design outcomes

Primary

Measure	Time frame
House-Brackmann scale (HBS)	6 months after onset of symptoms

Secondary

Measure	Time frame
facial disability index (FDI)	6 months after onset of symptoms
World Health Organization Quality of Life-BREF(WHOQOL-BREF)	6 months after onset of symptoms

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026